Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori

Journal of Clinical Gastroenterology

Volumn 42, Issue 4, 2008, Pages 351-355

  Sawaya, Manabu ^a   Yoshimura, Tetsuro ^a   Shimoyama, Tadashi ^a   Munakata, Akihiro ^a   Fukuda, Shinsaku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Helicobacter pylori; p53AIP1

Indexed keywords

PROTEIN P53;

ARTICLE; BIOPSY; CARCINOGENESIS; CHRONIC GASTRITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STOMACH CANCER; STOMACH MUCOSA;

EID: 41349120795     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318054493e     Document Type: Article

References (20)

1. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996;56:3238-3243.
2. Baik SC, Youn HS, Chung MH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 1996;56:1279-1282.
3. Kato M, Asaka M, Shimizu Y, et al. Multi-Centre Study Group. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Aliment Pharmacol Ther. 2004;20(suppl 1):85-89.
4. Achanta G, Huang P. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 2004;64:6233-6239.
5. Tanaka H, Arakawa H, Yamaguchi T, et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature. 2000;404:42-49.
6. Yamaguchi T, Matsuda K, Sagiya Y, et al. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Cancer Res. 2001;15:8256-8262.
7. Hsu PI, Lai KH, Chien EJ, et al. Impact of bacterial eradication of the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis. Anticancer Res. 2000;20:1221-1228.
8. Nardone G, Staibano S, Rocco A, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut. 1999;44:789-799.
9. Oda K, Arakawa H, Tanaka T, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 2000;102:849-862.
10. Yoshida K, Liu H, Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem. 2006;281:5734-5740.
11. Okumura S, Arakawa H, Tanaka T, et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Molecular Cell. 2001;8:85-94.
12. Xia HHX, Tally NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implication in gastric carcinogenesis. Am J Gastroenterol. 2001;96:16-26.
13. Yoshimura T, Shimoyama T, Tanaka M, et al. Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J Clin Pathol. 2000;53:532-536.
14. Chang CS, Chen WN, Lin HH, et al. Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma. World J Gastroenterol. 2004;10:2232-2240.
15. Murakami K, Fujita T, Kodama M, et al. Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. J Gastroenterol. 2002;37(suppl 13):1-5.
16. Yoshimura T, Shimoyama T, Fukuda S, et al. Most gastric cancer occurs on the distal side of the endoscopic atrophic border. Scand J Gastroenterol. 1999;34:1077-1081.
17. Ricevuto E, Ficorella C, Fusso C, et al. Molecular diagnosis of p53 mutation in gastric carcinoma by touch preparation. Am J Pathol. 1996;48:405-413.
18. Shepherd T, Tolbert D, Benedetti J, et al. Alterations in exon 4 of the p53 gene in gastric cancer. Gastroenterology. 2000;118:1039-1044.
19. Leung WK, Kim JJ, Kim JG, et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol. 2000;156:537-543.
20. Unger Z, Molnar B, Pronai L, et al. Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol. 2003;15:389-393.